{"SPADE_N_14566": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14566", "Peptide Name": "L5A (Synthetic AMPs, PG-1 analog, Arg-rich, 2S=S, UCSS1a)", "Source": "amino acid SUBSTITUTION, pig cathelicidin analog, animal-derived, natural derivatives", "Family": "Not found", "Gene": "Not found", "Sequence": "RGGRACYCRRRFCVCVGR", "Sequence Length": 18, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2118.54, "PI": 10.66, "Hydrophobicity": -0.36, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Bolosov IA, Panteleev PV, Sychev SV, Khokhlova VA, Safronova VN, Toropygin IY, Kombarova TI, Korobova OV, Pereskokova ES, Borzilov AI, Ovchinnikova TV, Balandin SV.2023", "Reference": "Pharmaceutics. 2023 Jul 30;15(8):2047. doi: 10.3390/pharmaceutics15082047.PubMed", "Title": "Design of Protegrin-1 Analogs with Improved Antibacterial Selectivity."}], "Frequent Amino Acids": "RCG", "Absent Amino Acids": "DEHIKLMNOPQSTUW", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 14, "Positive Residues": 6, "Negative Residues": 0, "Net Charge": 6, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (94.44%) toProtegrin 1R: 33%, C: 22%, G: 17%.Activity: active against E. coli ATCC 25922 or ML35p or BW 25113 (MIC 0.125-0.5 uM), P. aeruginosa PAO1 or ATCC 27853 (MIC 0.25-0.5 uM), A. baumannii (MIC 0.25 uM), K. pneumoniae ATCC 700603 (MIC 1 uM), S. aureus 209P or ATCC 29213 (MIC 1 uM), and M. luteus B-1314 (MIC 0.5 uM).In vitro toxicity: 40.3% hemolysis at 64 uM, less than WT PG-1.Recombinant production:bacteria:Escherichia coli: recombinant peptide was obtained and used.", "Similar Sequences": [{"SPADE_ID": "SPADE_N_07318", "Similarity": 1.0, "Sequence": "VSRRRRRRGGRRRR"}, {"SPADE_ID": "SPADE_N_11055", "Similarity": 1.0, "Sequence": "KNKRKRRRRRRGGRRRR"}, {"SPADE_ID": "SPADE_UN_11384", "Similarity": 1.0, "Sequence": "TLISWIKNKRKQRPRVSRRRRRRGGRRRR"}]}}}